EUVIMEDEUVIMED entdecken
Crossref

Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization

Catalina Amador iD, Julio C Poveda, Ibraheem Mohammed, Alyssa Bouska iD, Elizabeth Hyjek iD, Sarah Gibson iD, Pedro Horna iD, Karen L Rech iD, Juan C Ramos, Katiana S Delma, Justin W Koepplin, Lynn C Moscinski und 5 weitere

American Journal of Clinical Pathology · 05.05.2026 · 165 (5)

DOI: 10.1093/ajcp/aqag030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 10.05.2026. Verfasst von Catalina Amador und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL, United States. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, In Situ Hybridization, Retroviridae Proteins, RNA, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Diagnosing adult T-cell leukemia/lymphoma (ATLL) remains challenging due to its clinical and histopathologic heterogeneity. While HTLV-1 serology is a key diagnostic criterion, it is often unavailable at the time of diagnosis and does not confirm viral integration in tumor cells. The HTLV-1–encoded HBZ RNA is a reliable diagnostic biomarker for ATLL. We evaluated the diagnostic performance of RNAscope in situ hybridization (ISH) for HBZ RNA in formalin-fixed, paraffin-embedded (FFPE) tissues to distinguish ATLL from other T-cell lymphomas.

Methods

HBZ ISH was evaluated in 72 cases, including 52 ATLLs and 20 non-ATLL T-cell lymphomas, to determine diagnostic sensitivity and specificity, interobserver agreement, interlaboratory reproducibility, and comparison with digital gene expression.

Results

This assay demonstrated 86.5% sensitivity and 100% specificity, with sensitivity improving to 97% when excluding bone marrow clot sections and FFPE blocks older than 5 years. Interobserver agreement among 3 pathologists was excellent (κ = 0.92, percent agreement: 94%). Interlaboratory reproducibility of HBZ ISH was high, with 93% to 95% concordance across these Clinical Laboratory Improvement Amendments–certified laboratories. HBZ RNA ISH–positive cases demonstrated significantly higher HBZ gene expression levels by digital gene expression profiling.

Conclusions

We established HBZ ISH as a reliable tissue-based surrogate for HTLV-1 infection in ATLL. This assay will enhance diagnostic accuracy, expedite definitive diagnosis, and improve patient selection for targeted therapies and clinical trials, particularly in regions with a high prevalence of HTLV-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia-Lymphoma, Adult T-CellIn Situ HybridizationRetroviridae ProteinsRNA, ViralBasic-Leucine Zipper Transcription FactorsHumansSensitivity and SpecificityHuman T-lymphotropic virus 1Reproducibility of ResultsAdultFemaleMaleAgedMiddle AgedBiomarkers, TumorHTLV-I Infections

Stichwörter der Autor:innen

HBZ RNA ISHHTLV-1T-cell lymphomaadult T-cell leukemia/lymphoma

Substanzen

HBZ protein, human T-cell leukemia virus type IRetroviridae ProteinsRNA, ViralBasic-Leucine Zipper Transcription FactorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL, United States.
  • Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States.
  • Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States.
  • Department of Pathology/Hematopathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, FL, United States.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, AZ, United States.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.

ORCID-Profile: Catalina Amador, Alyssa Bouska, Elizabeth Hyjek, Sarah Gibson, Pedro Horna, Karen L Rech, Daniel P Cassidy, Lubomir Sokol, Javeed Iqbal, Jennifer R Chapman

Zitieren

APA

Amador, C., Poveda, J. C., Mohammed, I., Bouska, A., Hyjek, E., Gibson, S., Horna, P., Rech, K. L., Ramos, J. C., Delma, K. S., Koepplin, J. W., Moscinski, L. C., Cassidy, D. P., Dicaudo, D. J., Sokol, L., Iqbal, J., & Chapman, J. R. (2026). Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization. American Journal of Clinical Pathology, 165(5). https://doi.org/10.1093/ajcp/aqag030

Vancouver

Amador C, Poveda JC, Mohammed I, Bouska A, Hyjek E, Gibson S, et al. Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization. American Journal of Clinical Pathology. 2026;165(5). doi:10.1093/ajcp/aqag030

BibTeX
@article{Amador2026,
  author = {Amador, Catalina and Poveda, Julio C and Mohammed, Ibraheem and Bouska, Alyssa and Hyjek, Elizabeth and Gibson, Sarah and Horna, Pedro and Rech, Karen L and Ramos, Juan C and Delma, Katiana S and Koepplin, Justin W and Moscinski, Lynn C and Cassidy, Daniel P and Dicaudo, David J and Sokol, Lubomir and Iqbal, Javeed and Chapman, Jennifer R},
  title = {Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization},
  journal = {American Journal of Clinical Pathology},
  year = {2026},
  volume = {165},
  number = {5},
  doi = {10.1093/ajcp/aqag030}
}
Kostenlos starten →